Clinical Trial Update: A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 study of Pegcetacoplan for transplant-associated thrombotic microangiopathy after hematopoietic stem cell transplantation completed; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transplant-associated Thrombotic Microangiopathy

Drugs mentioned

• Pegcetacoplan (Pegcetacoplan)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Transplant-Associated Thrombotic Microangiopathy | Phase 2 | Status: COMPLETED | Results posted: 2025-11-28